SEC Form 4 · accession 0000920465-15-000082
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George F Tidmarsh
Officer — President, CEO & Secretary · Director
Period of report
Dec 21, 2015
Accepted (ET)
Dec 23, 2015 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $28.24 | Dec 21, 2015 | A | 289,000 | A | — | Dec 21, 2025 | Common Stock | 289,000 | 289,000 | D |
Explanation of responses
- F1This option represents a right to purchase a total of 289,000 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on December 21, 2016, with the remaining 216,750 shares vesting monthly thereafter over the next three years.